期刊文献+

内蒙古自治区甲型H1N1流感疫苗疑似预防接种异常反应监测分析 被引量:1

Surveillance and Analysis on Results of Adverse Events Following Immunization Against Pandemic Influenza A(HlN1) in Inner Mongolia Autonomous Region,China
原文传递
导出
摘要 目的监测并分析甲型H1N1流感疫苗的安全性和疑似预防接种异常反应(AEFI)发生特征,评价AEFI监测系统运转情况。方法对内蒙古2009-2010年甲型H1N1流感疫苗接种后发生并报告的预防接种异常反应进行调查分析。结果全自治区报告疑似预防接种异常反应88例,一般反应67例,异常反应17例,偶合症1例,心因性反应2例,待定1例。24 h内监测到AEFI病例62例。异常反应中,过敏性皮疹占52.94%。结论甲型H1N1流感疫苗安全性较好。 Objective To analyze the occurrence characteristic of suspected adverse events following immunization (AEFI) against influenza A (HIN1) and the safety of the vaccine based on the population in Inner Mongolia, to assess the run- ning situation of AEFI surveillance system. Methods The adverse events following immunization against influenza A (H1N1) in Inner Mongolia from 2009 to 2010 were studied and analyzed. Results Eighty - eight cases of AEFI were reported and in- vestigated. Among them, there were 67 general reaction cases, 17 vaccine abnormal reaction cases, 1 coincident case, 2 psycho- genic reaction cases, and 1 undetermined case. Meanwhile, 62 cases of AEFI were reported within 24 hours. 52.94 % of abnormal reactions eases were rash. Conclusion Influenza A (H1N1) vaccines used in Inner Mongolia are safe.
出处 《实用预防医学》 CAS 2012年第9期1318-1320,共3页 Practical Preventive Medicine
关键词 甲型H1N1流感疫苗 异常反应 监测 Influenza A ( H1 N1 ) vaccine Adverse events following immunization Surveillance
  • 相关文献

参考文献8

  • 1CI)C. Update: swine influenza A (H1N1) infections- C.alifomia and Texas, April 2009[J]. MMWR Morb Mortal Wkly Rep, 2009, 58: 435 - 437.
  • 2CDC. Swine influenza A (H1N1) infections in two children - Southern California, March- April 2009[J]. MMWR Morb Mortal Wkly Rep, 2009, 58 : 200 - 202.
  • 3WHO. New influenza A (H1NI) virus: global epidemiological situ-ation, June 2009[J]. Wkly Epidemiol Rec, 2009, * 4:249 257.
  • 4卫生部办公厅.全国疑似预防接种异常反应监测方案[z].2010:2.
  • 5范耀春,李彬,闫绍宏.内蒙古自治区2010年麻疹疫苗强化免疫异常反应监测[J].实用预防医学,2011,18(10):1870-1872. 被引量:2
  • 6陈恩富,胡昱,凌罗亚,李倩,陈雅萍,戚小华,陈永弟.甲型H_1N_1流感疫苗的疑似预防接种异常反应监测[J].浙江预防医学,2010,22(5):1-3. 被引量:22
  • 7CIr. Surmmry of 2009 Monovalent H1N1 Influenza Vaccine Data Vaccine Adverse Event Reporting System Data through February 26 2010 [ EB]. Accessed at http://vaers, hhs. gov/resources/2010H 1NI Summary-May04. pdf.
  • 8Liang XF, Wang HQ, Wang JZ, et ah Safety and inununogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a muhienter, double -blind, randomized, placebo controlled trial[J]. Lancet, 2010, 375 (9708):56 66.

二级参考文献12

  • 1张守荣,赵建海,朱向路,张永基,马小军.青海省2006年麻疹疫苗强化免疫结果分析[J].青海医药杂志,2008,38(6):9-11. 被引量:7
  • 2张红,李飒,董捷.麻疹强化免疫中异常反应诱发因素的分析[J].中国自然医学杂志,2006,8(1):37-39. 被引量:7
  • 3左树岩,梁晓峰,殷大鹏,尤雪丹,郭飚,童亦兵,朱青,张大勇,杜雯,Lisa lee,Yoshihiro Takashima,于竞进.贵州省2003~2004年麻疹疫苗强化免疫效果评价[J].中国计划免疫,2006,12(1):7-12. 被引量:67
  • 4European Medicines Agency.Fifth pandemic pharmacovigilance weekly update[R].www.emea.europa.eu,6 January 2010.
  • 5Medicine and Healthcare Products Regulatory Agency.Suspected Adverse Drug Reaction(ADR) Analysis:Swine Flu Vaccines-H1N1(Celvapan and Pandemrix)[R].www.mhra.gov.uk,5 March 2009.
  • 6XiaoFeng Liang,HuaQing Wang,JunZhi Wang,et al.Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China:a multicentre,double-blind,randomised,placebo-controlled trial[J].Lancet,2010,375(9708):56-66.
  • 7FengCai Zhu,Hua Wang,HanHua Fang,et al.A Novel Influenza A (H1N1) Vaccine in Various Age Groups[J].N Engl J Med,2009,361(25):2414-2423.
  • 8Izurieta HS,Haber P,Wise RP,et al.Adverse events reported following live,cold-adapted,intranasal influenza vaccine[J].JAMA,2005,294(21):2720-2725.
  • 9卫生部办公厅,国家食品药品监管局办公室全国疑似预防接利,异常反应监测方案[z]2010.
  • 10周莉薇,芮建国,付益仁,李海军,李淑霞,逯伟,夏清.宁夏2005年麻疹疫苗强化免疫效果评价[J].医学动物防制,2007,23(11):820-822. 被引量:14

共引文献32

同被引文献17

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部